Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Marc Jolicoeur

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
European Heart Journal|January 10, 2018
Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trialsTimothy D Henry, Douglas W Losordo, Jay H Traverse, et al.
International Journal of Cardiology|May 1, 2018
Understanding the patient perspective on research access to national health records databases for conduct of randomized registry trialsRobert Avram, Guillaume Marquis-Gravel, François Simard, et al.
The Canadian Journal of Cardiology|March 20, 2012
Management of patients with refractory angina: Canadian Cardiovascular Society/Canadian Pain Society joint guidelinesMichael McGillion, Heather M Arthur, Allison Cook, et al.
Journal of Thrombosis and Thrombolysis|February 17, 2010
Highlights from the II International Symposium of Thrombosis and Anticoagulation (ISTA), October 22-23, 2009, São Paulo, BrazilRenato D Lopes, David Garcia, Richard C Becker, et al.
JACC. Cardiovascular Interventions|August 6, 2016
The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory AnginaThomas J Povsic, Timothy D Henry, Jay H Traverse, et al.
International Journal of Cardiology|April 2, 2019
Does prior coronary angioplasty affect outcomes of surgical coronary revascularization? Insights from the STICH trialJose C Nicolau, Susanna R Stevens, Hussein R Al-Khalidi, et al.
The Canadian Journal of Cardiology|August 18, 2020
Immediate vs Delayed Stenting in ST-Elevation Myocardial Infarction: Rationale and Design of the International PRIMACY Bayesian Randomized Controlled TrialE Marc Jolicoeur, Nandini Dendukuri, Patrick Belisle, et al.
Journal of the American College of Cardiology|April 22, 2017
Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis: An Expert StatementCarlos E Ruiz, Rebecca T Hahn, Alain Berrebi, et al.
European Heart Journal|April 22, 2017
Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical ProsthesisCarlos E Ruiz, Rebecca T Hahn, Alain Berrebi, et al.
Journal of Thrombosis and Thrombolysis|May 7, 2011
Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, BrazilRenato D Lopes, Richard C Becker, John H Alexander, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
European Heart Journal|January 10, 2018
Autologous CD34+ cell therapy improves exercise capacity, angina frequency and reduces mortality in no-option refractory angina: a patient-level pooled analysis of randomized double-blinded trialsTimothy D Henry, Douglas W Losordo, Jay H Traverse, et al.
International Journal of Cardiology|May 1, 2018
Understanding the patient perspective on research access to national health records databases for conduct of randomized registry trialsRobert Avram, Guillaume Marquis-Gravel, François Simard, et al.
The Canadian Journal of Cardiology|March 20, 2012
Management of patients with refractory angina: Canadian Cardiovascular Society/Canadian Pain Society joint guidelinesMichael McGillion, Heather M Arthur, Allison Cook, et al.
Journal of Thrombosis and Thrombolysis|February 17, 2010
Highlights from the II International Symposium of Thrombosis and Anticoagulation (ISTA), October 22-23, 2009, São Paulo, BrazilRenato D Lopes, David Garcia, Richard C Becker, et al.
JACC. Cardiovascular Interventions|August 6, 2016
The RENEW Trial: Efficacy and Safety of Intramyocardial Autologous CD34(+) Cell Administration in Patients With Refractory AnginaThomas J Povsic, Timothy D Henry, Jay H Traverse, et al.
International Journal of Cardiology|April 2, 2019
Does prior coronary angioplasty affect outcomes of surgical coronary revascularization? Insights from the STICH trialJose C Nicolau, Susanna R Stevens, Hussein R Al-Khalidi, et al.
The Canadian Journal of Cardiology|August 18, 2020
Immediate vs Delayed Stenting in ST-Elevation Myocardial Infarction: Rationale and Design of the International PRIMACY Bayesian Randomized Controlled TrialE Marc Jolicoeur, Nandini Dendukuri, Patrick Belisle, et al.
Journal of the American College of Cardiology|April 22, 2017
Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis: An Expert StatementCarlos E Ruiz, Rebecca T Hahn, Alain Berrebi, et al.
European Heart Journal|April 22, 2017
Clinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical ProsthesisCarlos E Ruiz, Rebecca T Hahn, Alain Berrebi, et al.
Journal of Thrombosis and Thrombolysis|May 7, 2011
Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, BrazilRenato D Lopes, Richard C Becker, John H Alexander, et al.
Pageof 6